Scynexis (SCYX) Total Liabilities (2013 - 2026)
Scynexis' (SCYX) quarterly Total Liabilities came in at $36.3 million in Q1 2026, up 108.93% YoY from $17.4 million in Q1 2025, and up 276.32% on a QoQ basis from $9.7 million in Q4 2025.
Scynexis (SCYX) Total Liabilities (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Total Liabilities data on file, last reported at $36.3 million in Q1 2026.
- Quarterly Total Liabilities rose 108.93% year-over-year to $36.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.3 million (up 108.93% YoY) and the FY2025 annual result came in at $9.7 million, down 72.86% from the prior year.
- Total Liabilities grew to $36.3 million in Q1 2026, from $9.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $100.2 million in Q1 2023 to a low of $9.7 million in Q4 2025.
- A 5-year average of $51.7 million and a median of $47.4 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2025 — Total Liabilities sank 72.86% — and 2026, when it jumped 108.93%.
- Tracing SCYX's Total Liabilities over 5 years: stood at $84.6 million in 2022, then plunged by 34.44% to $55.4 million in 2023, then slumped by 35.86% to $35.6 million in 2024, then plunged by 72.86% to $9.7 million in 2025, then soared by 276.32% to $36.3 million in 2026.
- The last three Total Liabilities figures came in at $36.3 million (Q1 2026), $9.7 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | 8.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.04 Mn |
| Mar 31, 2026 | 36.32 Mn |
| Dec 31, 2025 | 9.65 Mn |
| Sep 30, 2025 | 14.64 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Mar 31, 2025 | 17.38 Mn |
| Dec 31, 2024 | 35.57 Mn |
| Sep 30, 2024 | 40.51 Mn |
| Jun 30, 2024 | 47.40 Mn |
| Mar 31, 2024 | 44.15 Mn |
| Dec 31, 2023 | 55.45 Mn |
| Sep 30, 2023 | 56.56 Mn |
| Jun 30, 2023 | 61.78 Mn |
| Mar 31, 2023 | 100.21 Mn |
| Dec 31, 2022 | 84.58 Mn |
| Sep 30, 2022 | 95.08 Mn |
| Jun 30, 2022 | 90.13 Mn |
| Mar 31, 2022 | 72.64 Mn |
| Dec 31, 2021 | 78.58 Mn |
| Sep 30, 2021 | 72.27 Mn |